NCT00806533View on ClinicalTrials.gov

Non-Interventional (Observational) Post-Authorization Safety Study of HES 130/0.42 in Paediatric Patients

CompletedOBSERVATIONAL
Enrollment

1,130

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Surgery
Interventions
DRUG

HES 130 / 0.42 (Venofundin 6%, Tetraspan 6%)

solution for intravenous infusion applied according to SmPC

Trial Locations (10)

Unknown

Donauspital SMZ-OST, Vienna

Clinic of Children's Anaesthesiology and Resuscitation, Brno

Clinic of Anaesthesiology and Resuscitation, Prague

Klinik für Anästhesiologie und Intensivmedizin, TU Universität Dresden, Dresden

Klinik für Anästhesiologie und Intensivmedizin, Medizinische Hochschule Hannover, Hanover

Klinikum Mannheim, Mannheim

Olgahospital, Stuttgart

S. Orsola Hospital, University hospital, Bologna

Academic Mesich Centrum (AMC), Amsterdam

Erasmus MC, Univesity Medical Center Rotterdam, Sophias's Children's Hospital (SKZ), Rotterdam

All Listed Sponsors
lead

B. Braun Melsungen AG

INDUSTRY

NCT00806533 - Non-Interventional (Observational) Post-Authorization Safety Study of HES 130/0.42 in Paediatric Patients | Biotech Hunter | Biotech Hunter